Integer - ITGR Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Integer in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ITGR shares.
View ITGR analyst ratings or view top-rated stocks.

1 brokers have issued 1-year price targets for Integer's shares. Their ITGR share price forecasts range from $84.00 to $90.00. On average, they anticipate the company's share price to reach $87.00 in the next twelve months. This suggests a possible upside of 19.7% from the stock's current price.
View analysts price targets for ITGR or view top-rated stocks among Wall Street analysts.

Integer's stock was trading at $68.46 at the beginning of the year. Since then, ITGR stock has increased by 6.2% and is now trading at $72.68.
View the best growth stocks for 2023 here.

Integer saw a drop in short interest in the month of December. As of December 30th, there was short interest totaling 690,900 shares, a drop of 11.0% from the December 15th total of 775,900 shares. Based on an average daily trading volume, of 217,600 shares, the days-to-cover ratio is presently 3.2 days. Currently, 2.1% of the shares of the company are short sold.
View Integer's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our ITGR earnings forecast.

Integer will be holding an earnings conference call on Thursday, February 16th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 647-362-9199 with passcode "9252310".

Integer Holdings Co. (NYSE:ITGR) issued its quarterly earnings results on Thursday, October, 28th. The medical equipment provider reported $1.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.09. The medical equipment provider had revenue of $305.57 million for the quarter, compared to the consensus estimate of $303.23 million. Integer had a trailing twelve-month return on equity of 9.24% and a net margin of 5.47%. The firm's quarterly revenue was up 29.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.50 EPS.

Integer updated its fourth quarter earnings guidance on Monday, January, 30th. The company provided earnings per share (EPS) guidance of $1.08-1.11 for the period, compared to the consensus EPS estimate of $1.02. The company issued revenue guidance of $370-372 million, compared to the consensus revenue estimate of $356.45 million.

40 employees have rated Integer Chief Executive Officer Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), Procter & Gamble (PG), Gilead Sciences (GILD), Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

Integer trades on the New York Stock Exchange (NYSE) under the ticker symbol "ITGR."

Integer's stock is owned by many different retail and institutional investors. Top institutional investors include New York State Common Retirement Fund (1.37%), Allspring Global Investments Holdings LLC (1.05%), Tributary Capital Management LLC (0.83%), Congress Asset Management Co. MA (0.76%), Diamond Hill Capital Management Inc. (0.72%) and Envestnet Asset Management Inc. (0.42%). Insiders that own company stock include Anthony W Borowicz, Bill R Sanford, Bill R Sanford, Carter Houghton, Jean M Hobby, Joseph F Flanagan, Joseph W Dziedzic and Pamela G Bailey.
View institutional ownership trends.

Shares of ITGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ITGR stock can currently be purchased for approximately $72.68.

Integer (NYSE:ITGR) has a market capitalization of $2.41 billion and generates $1.22 billion in revenue each year. The medical equipment provider earns $96.81 million in net income (profit) each year or $2.15 on an earnings per share basis.

The company employs 9,000 workers across the globe.

Integer's mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The official website for the company is www.integer.net. The medical equipment provider can be reached via phone at (214) 618-5243, via email at ir@integer.net, or via fax at 716-759-5654.